News

TELO Rises on Promising Telomir-1 Preclinical Results
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) is among the 10 Best Growth Stocks Under $100 to Buy Now. On Wednesday, Telomir ...
Investornewsbreaks Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Breakthrough With Telomir-1 In Wilson's Disease Model
Telomir Pharmaceuticals (NASDAQ: TELO) announced new preclinical data showing its lead candidate, Telomir-1, significantly reversed neurological, liv ...